grief - Nursing Case Study

Pathophysiology

• Primary mechanism: Neurobiological response - Grief triggers the activation of the brain's limbic system, particularly the amygdala and hippocampus, leading to heightened emotional responses and memory processing changes, which are pivotal in experiencing and processing loss.

• Secondary mechanism: Stress hormone regulation - The hypothalamic-pituitary-adrenal (HPA) axis is activated during grief, resulting in increased cortisol levels. This stress response can affect immune function, sleep patterns, and overall emotional regulation, contributing to the physical symptoms of grief.

• Key complication: Prolonged grief disorder - When these mechanisms become chronic, they may lead to prolonged grief disorder, characterized by persistent, intense sorrow and functional impairment, necessitating clinical intervention for resolution.

Patient Profile

Demographics:

42, female, school teacher

History:

• Key past medical history: Mild hypertension, history of anxiety

• Current medications: Lisinopril 10 mg daily, Sertraline 50 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Intense sadness and difficulty coping after the recent loss of a spouse

• Key symptoms: Persistent crying, insomnia, loss of appetite, difficulty concentrating, occasional palpitations

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

Change in Patient Status:

Two weeks following the initial assessment, the patient returns for a follow-up appointment, reporting an exacerbation of symptoms. She describes a deeper level of emotional despondency, with her sadness now accompanied by feelings of hopelessness and despair. Her insomnia has worsened, with nights of no more than two to three hours of fragmented sleep. The appetite loss has become more pronounced, resulting in a weight loss of approximately six pounds since her last visit. The patient also expresses increased difficulty in performing daily tasks and responsibilities, which is impacting her job performance as a school teacher. She notes that her concentration issues have led to several errors at work, causing further anxiety and distress.

Upon examination, her vital signs reveal a blood pressure of 160/100 mmHg and a heart rate of 110 bpm. Her respiratory rate remains elevated at 22 breaths per minute, although her temperature is stable at 98.6°F. The patient's pallor and visible fatigue suggest the physiological toll of chronic sleep deprivation and nutritional deficits. Notably, the palpitations have become more frequent, and the patient describes them as unsettling, further exacerbating her anxiety. These changes indicate a progression towards a more severe form of prolonged grief disorder, with significant functional impairment and escalating stress responses.

Given these developments, clinical reasoning suggests a need to address both the physiological and psychological aspects of her condition. Adjustments to her current medication regimen, including a possible increase in her Sertraline dosage or the introduction of a short-term sleep aid, may be warranted. Additionally, referral to a mental health specialist for cognitive behavioral therapy (CBT) or grief counseling could provide essential support. Laboratory tests to assess cortisol levels and overall endocrine function may offer insights into the physiological stress response contributing to her symptoms, guiding a more targeted therapeutic approach.

Section 2

New Diagnostic Results:

Following the patient's report of exacerbated symptoms and functional impairment, a series of diagnostic tests were conducted to evaluate her physiological and psychological status further. The results reveal elevated cortisol levels, consistent with a heightened stress response, which may be contributing to her insomnia, anxiety, and palpitations. Thyroid function tests return slightly abnormal, indicating subclinical hypothyroidism, which could partially explain her fatigue and concentration difficulties. Additionally, a complete blood count shows mild anemia, likely exacerbated by her recent weight loss and poor nutritional intake.

These findings suggest that the patient's prolonged grief disorder is complicated by both endocrine dysregulation and nutritional deficiencies. The elevated cortisol levels underscore the need for interventions targeting stress management, while the thyroid imbalance and anemia warrant medical attention to optimize her physiological status. The healthcare team considers these results in adjusting the treatment plan, aiming to address the multifaceted nature of her condition.

In response to these diagnostic insights, a comprehensive management plan is devised. The patient's Sertraline dosage is increased to better manage her depressive symptoms, and a low-dose beta-blocker is introduced to alleviate the palpitations and potentially lower her blood pressure. The addition of iron supplements and dietary counseling is recommended to address anemia and nutritional deficits. Furthermore, an endocrinology referral is made to explore the thyroid issue more deeply. These targeted interventions aim to stabilize her physiological state, allowing her to engage more effectively in psychological therapies such as CBT, thereby addressing both the root and manifestations of her grief-related challenges.

Section 3

Response to Interventions:

After two weeks of implementing the revised treatment plan, the patient returns for a follow-up appointment. Her initial response to the interventions shows mixed results, highlighting both progress and areas that require further attention. The patient reports a slight improvement in her mood and a reduction in palpitations since the increase in Sertraline and the introduction of a low-dose beta-blocker. However, she continues to experience significant fatigue and concentration difficulties, suggesting that the thyroid imbalance and anemia may still be impacting her daily functioning.

Vital signs during the visit reveal a stabilized blood pressure of 118/76 mmHg and a heart rate of 78 bpm, indicating that the beta-blocker is effectively controlling her cardiovascular symptoms. Laboratory results show a modest improvement in hemoglobin levels, rising from 10.5 g/dL to 11.2 g/dL, suggesting that the iron supplements are starting to address the anemia. However, her thyroid function tests remain slightly abnormal, with a TSH level of 4.8 mIU/L, prompting further investigation into her subclinical hypothyroidism.

Despite these positive changes, the patient describes persistent insomnia and anxiety, particularly at night, which continues to disrupt her overall progress. This ongoing issue raises concerns about the adequacy of her stress management strategies. The healthcare team considers integrating additional non-pharmacological interventions, such as mindfulness-based stress reduction or yoga, to complement her current treatment regimen. A follow-up appointment with the endocrinologist is also prioritized to reassess her thyroid function and explore potential treatment adjustments. This comprehensive approach aims to further stabilize her physiological and psychological status, providing a more solid foundation for her ongoing recovery journey.

Section 4

Approximately three weeks after the follow-up appointment, the patient contacts her healthcare provider reporting a new development: an increase in muscle aches and joint stiffness, particularly in the mornings. She explains that these symptoms have been progressively worsening, making it difficult for her to perform daily activities and maintain her exercise routine. Concerned about these emerging symptoms, the healthcare team decides to re-evaluate her condition with a comprehensive assessment and additional diagnostic tests.

During the assessment, the patient appears visibly fatigued and mentions feeling more emotionally overwhelmed, despite her previous slight improvement in mood. Her vital signs remain stable, with a blood pressure of 116/74 mmHg and a heart rate of 76 bpm. However, a physical examination reveals mild swelling in her hands and fingers, and she demonstrates reduced range of motion in her wrists and knees. Given these findings, the healthcare provider orders a rheumatologic panel to rule out any autoimmune disorders that could explain her recent symptoms.

The laboratory results from the rheumatologic panel reveal elevated levels of antinuclear antibodies (ANA) and rheumatoid factor, pointing towards a possible autoimmune process. These findings suggest that the patient may be developing a condition such as rheumatoid arthritis or another connective tissue disorder. In light of this new complication, the healthcare team recognizes the need for an interdisciplinary approach, involving a rheumatologist to confirm the diagnosis and adjust her treatment plan accordingly. This step is critical to addressing the current complications and preventing further deterioration in her quality of life, while continuing to manage her existing conditions effectively.

Section 5

Following the initial findings and rheumatologic panel results, the healthcare team schedules a consultation with a rheumatologist to further evaluate the patient's symptoms and refine her diagnosis. During this consultation, the rheumatologist conducts a more detailed musculoskeletal examination and reviews the patient's medical history. The examination reveals increased tenderness in the patient's wrists and knees, with noticeable warmth over the joints. The patient reports that her morning stiffness lasts for over an hour before she can comfortably move. Additionally, the rheumatologist notes the presence of small nodules on the patient's elbows, which may be indicative of rheumatoid nodules, a common manifestation in rheumatoid arthritis.

The rheumatologist orders further diagnostic tests, including an erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) test, to assess the level of inflammation in the patient's body. The results show significantly elevated ESR and CRP levels, confirming active inflammation. Based on these findings, the rheumatologist diagnoses the patient with early-stage rheumatoid arthritis. This new diagnosis necessitates a revision of her treatment plan, which now includes the initiation of disease-modifying antirheumatic drugs (DMARDs) to control the progression of the disease and alleviate her symptoms.

In response to the new treatment plan, the healthcare team collaborates to ensure a comprehensive approach to the patient's care. A physical therapist is introduced to design an individualized exercise program aimed at maintaining joint flexibility and reducing stiffness, while a psychologist is involved to provide support for the patient's emotional well-being, considering the added stress of managing a chronic illness. The patient is educated on the importance of medication adherence and regular follow-up appointments to monitor her response to treatment and adjust the plan as needed. This interdisciplinary approach aims to address both the physical and emotional aspects of her condition, promoting overall well-being and preventing further complications.